CTNM CTNM
Company Profile ↓Company Overview
CTNM (CTNM) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -100.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -100.00% |
Stock Price Performance
| 1 Year: | +163.28% |
| 6 Months: | +0.39% |
| 3 Months: | +6.12% |
| 1 Month: | +4.88% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)55.64 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | 50.00M | 0 | - | 0 | 0 | - | - | - | - | - |
| Operating Income | -5.12M | 38.94M | -8.07M | -9.93M | -10.94M | -12.97M | -18.11M | -17.90M | -14.93M | -16.90M | -17.43M |
| Net Income | -4.82M | 41.56M | -6.25M | -8.42M | -9.01M | -10.27M | -15.99M | -16.04M | -12.79M | -14.46M | -15.15M |
| Diluted EPS | - | 0.84 | -2.69 | - | -0.39 | -0.40 | -0.62 | -0.62 | - | -0.39 | -0.40 |
| R&D Expense | 3.63M | 9.46M | 6.50M | 7.78M | 7.90M | 9.73M | 13.71M | 14.06M | 10.99M | 11.65M | 12.70M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 50.00M | 0 | - |
| Operating Income | 16.08M | -50.89M | -68.06M |
| Net Income | 22.72M | -42.26M | -59.98M |
| Diluted EPS | 0.08 | -2.18 | -2.17 |
| R&D Expense | 27.60M | 38.42M | 51.52M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | - | 130.39M | 212.85M | 276.64M |
| Total Equity | -93.21M | -67.94M | 198.07M | 260.99M |
| Cash & Equivalents | - | 15.53M | 21.94M | 75.60M |
| Total Liabilities | - | 5.70M | 14.78M | 15.65M |
| Current Liabilities | - | 5.48M | 9.97M | 9.74M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | 19.35M | -32.84M | -55.31M |
| Investing Cash Flow | -65.57M | -69.74M | -3.71M |
| Financing Cash Flow | 56.18M | 109.00M | 112.69M |
| Capital Expenditure | -414.00K | -514.00K | -231.00K |
| Free Cash Flow | 18.93M | -33.36M | -55.54M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | - | - | - |
| Operating Margin % | 32.2% | - | - |
| Net Margin % | 45.4% | - | - |
| ROE % | -33.4% | -21.3% | -23.0% |
| ROCE % | 12.9% | -25.1% | -25.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CTNM
CTNM (CTNM) insider schedules 2,500-share stock sale after recent 10b5-1 trades - Stock Titan
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNU0N1aTVBQmk1a1ZXTEJiaVNvQ1BNYTlnYy1FeTdNUFBhXzlFLWNYZlpObzVTaXIweWl0ZTFVSHUwU3JWaWNrbHNTWnE2RFlCUGQyNFZCTG51S3J3OFEtUl9rQ2Y4cmpXaXBwRTEyWWE0Y3NyMlk1Y0JMWERjTGRkWlpZNk1hUVJxS0lrX3…
CTNM Stock Price and Chart — NASDAQ:CTNM - TradingView
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE5ULW5rX0YzWDFndVExOTFHX2ZjbzZ0Y1NoUkVFWFhXSTROQU9wTjVHTkJ0OVF5akpBRkQ0V18zeUVnb1k1dklKdHk4MWE3OHpOX2h4bVhVUjVZMFZH?oc=5" target="_blank">CTNM Stock Price and Chart — NASDAQ:CTNM</a…
Contineum reports $15.2 million second quarter loss - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxQM0diZHowenNTYk9GSmdpVkRxSTlNamlLXzNvNWUxRmFYYjAzZzlRSnQ2MDA0cnpRSV9pd1dKci0xbl9KdVFVaVhtY3BEb0xCMXpxeE1aeTNjemxsaEo2NUpPT1JZbmhRN1RoRUdwc3haZnhKa05xbnFiOVdIMGhiZWtFaFFnRV8wdlN6ZE…
CTNM Maintained by RBC Capital -- Price Target Raised to $23.00 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNd2dpT0lZOVFxWGtaWk03eFE1WkpXTjF2MjRUdUY2YkNMZkx0cDhVeVU3Rjl4NFgwZ00zY3dJRzlqUlNTZ2FhZTdBU0p5alhBMHZOeno5VGJSN1Rzbm9xR2tGeXFqTDZ1cDBlb05uSno3dzBBYXdoaVI3cEN4YmZ2dGVtRFBFMnZKV1B4U1…
Contineum Therapeutics CEO Stengone sells $40,029 of common stock - Investing.com
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxQMEZ5WTZEWTUzeHVRMWxQREF2Q0pZM3ZLbGE4cG1hQ3JoUW90bWtHTmNER2k0RUNUeWF6RHRhQ2xsWl9fTVJZMDgzdGpfaWxtUG5XWlBKNmpMYUlidms3Y0lrTWFuNVhLQ2YzMlE0Z2ZEdGtvMzViUk5RNVZkZFVPeGJ5dHUwYXozXzJtMV…
Contineum Therapeutics (CTNM) CEO sells 2,500 shares after option exercise - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNUnR3Q0JET2JySnVyQW9iSnpyZ0ZlNlFqdjVkU042TFVGUUFjQUxRTzc1MWFFMlFodW9ad0pzN2s2ZERseDd2TUFtLThtWnhSSm1qUHBia0ZnVER5eU9uaWpKRjZ6aWhRTzM5MjVLSmNNUkszT0h3cmpoRDVQNW9xRkM0Yk15LVI5V1lLcC…
CTNM — Frequently Asked Questions
What is the current share price of CTNM?
As of 2026-08-05 17:25 PDT, CTNM trades at $15.27 on NASDAQ/NYSE. Its 52-week range is $5.80 to $16.39.
What is the P/E ratio of CTNM?
CTNM trades at a trailing price-to-earnings (P/E) ratio of -7.04.
What is the return on equity (ROE) of CTNM?
CTNM has a return on equity (ROE) of -22.98%. Its return on capital employed (ROCE) is -25.50%.
Is CTNM a good stock to buy?
This page provides a data-driven analysis of CTNM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.